Medicare Enrolled

Dr. Andrew Dvorak, M.D.

Ophthalmology · Conroe, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
400 S LOOP 336 W, Conroe, TX 77304
9395394500
In practice since 2006 (20 years)
NPI: 1770561714 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Dvorak from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dvorak? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Dvorak

Dr. Andrew Dvorak is an ophthalmology in Conroe, TX, with 20 years in practice. Based on federal Medicare data, Dr. Dvorak performed 6,550 Medicare services across 1,467 unique beneficiaries.

Between the years covered by Open Payments, Dr. Dvorak received a total of $5,088 from 27 pharmaceutical and/or device companies across 158 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Dvorak is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 14% volume in TX$ $5,088 industry payments

Medicare Practice Summary

Medicare Utilization ↗
6,550
Medicare services
Top 14% in TX for ophthalmology
1,467
Unique beneficiaries
$137
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~328 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Eye injection (Vabysmo/faricimab)3,000$29$92
Aflibercept eye injection (Eylea)874$693$2,565
Retinal imaging (OCT scan)873$29$135
Comprehensive eye exam, established patient616$84$239
Eye injection for retinal disease517$85$522
Corneal topography and eye depth measurement99$30$212
Optic nerve imaging (OCT scan)76$24$135
Eye exam, established patient, focused73$45$174
Visual field test, extended73$46$179
Cataract surgery with lens implant71$402$2,939
Comprehensive eye exam, new patient61$92$284
Retinal photography (fundus photo)53$24$140
Office visit, established patient (30-39 min)40$100$196
Complex removal of cataract with insertion of prosthetic lens32$565$3,875
Removal of recurring cataract in lens capsule using a laser28$258$776
Injection, bevacizumab, 10 mg28$54$123
Office visit, established patient (20-29 min)22$67$134
Exam of retinal blood vessels using a special camera after injection of a dye14$107$345
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.1% high complexity
82.2% medium
16.7% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$5,088
Total received (2018-2024)
Avg $727/year across 7 years
Top 22% in TX for ophthalmology
27
Companies
158
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,020 (98.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$68 (1.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$842
2023
$1,387
2022
$1,026
2021
$578
2020
$333
2019
$417
2018
$506

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Alcon Vision LLC
$955
Bausch & Lomb, a division of Bausch Health US, LLC
$662
ABBVIE INC.
$517
Regeneron Healthcare Solutions, Inc.
$514
AbbVie Inc.
$463
Oyster Point Pharma, Inc.
$325
Johnson & Johnson Surgical Vision, Inc.
$268
Genentech USA, Inc.
$232
Sun Pharmaceutical Industries Inc.
$194
Bausch & Lomb Americas Inc.
$182
Allergan, Inc.
$173
Aerie Pharmaceuticals, Inc.
$146
Optos, Inc.
$71
Alcon Laboratories Inc
$49
RxSight Inc
$45
Novartis Pharmaceuticals Corporation
$39
Apellis Pharmaceuticals, Inc.
$36
Kala Pharmaceuticals, Inc.
$33
Allergan Inc.
$30
Rayner Intraocular Lenses Limited
$30
Horizon Therapeutics plc
$24
Amgen Inc.
$24
Glaukos Corporation
$23
SUN PHARMACEUTICAL INDUSTRIES INC.
$18
Ocular Therapeutix, Inc.
$14
BIOTISSUE HOLDINGS INC.
$14
TissueTech, Inc.
$8
Top 3 companies account for 41.9% of total payments
Associated products mentioned in payments ›
AcrySof · AcrySof IQ VIVITY IOL · BESIVANCE · COMBIGAN · Cequa · Clareon · DEXTENZA · DURYSTA · EYLEA · EYLEA AFLIBERCEPT INJECTION · EYLEA HD · INVELTYS · LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD) · LOTEMAX · LOTEMAX GEL · LOTEMAX SM · LUMIGAN · Lucentis · Omidria · P200DTx · PanOptix · Prokera · RESTASIS · RESTASIS MULTIDOSE · RXSIGHT CONTACT LENS · Rhopressa · Rocklatan · Simbrinza · Syfovre · TECNIS IOL · TEPEZZA · TORIC · TYRVAYA · VABYSMO · VUITY · VYZULTA · Vabysmo · XELPROS · XEN GLAUCOMA TREATMENT SYSTEM · XIIDRA · iStent Trabecular Micro-Bypass System Model iS3 · rocklatan
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $78 per 100 Medicare services performed
Looking for a ophthalmology in Conroe?
Compare ophthalmologys in the Conroe area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologys nearby

Geographic Context

Ophthalmologys within 10 mi
45
Per 100K population
6.9
County median income
$97,266
Nearest hospital
HCA HOUSTON HEALTHCARE CONROE
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Dvorak is a mixed practice specialist, with above-average Medicare volume (top 14% in TX), and low-engagement industry engagement, with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Dvorak experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. Dvorak performed 3,000 eye injection (vabysmo/faricimab) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Dvorak receive payments from pharmaceutical companies?
Yes. Dr. Dvorak received a total of $5,088 from 27 companies across 158 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dvorak's costs compare to other ophthalmologys in Conroe?
Dr. Dvorak's average Medicare payment per service is $137. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dvorak) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →